401 related articles for article (PubMed ID: 25590298)
1. Mechanisms and applications of interleukins in cancer immunotherapy.
Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
[TBL] [Abstract][Full Text] [Related]
2. Interleukins and cancer immunotherapy.
Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
[TBL] [Abstract][Full Text] [Related]
3. Fighting cancers from within: augmenting tumor immunity with cytokine therapy.
Pellegrini M; Mak TW; Ohashi PS
Trends Pharmacol Sci; 2010 Aug; 31(8):356-63. PubMed ID: 20561689
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
Floros T; Tarhini AA
Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
[TBL] [Abstract][Full Text] [Related]
5. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
Setrerrahmane S; Xu H
Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
[TBL] [Abstract][Full Text] [Related]
6. The IL-2 cytokine family in cancer immunotherapy.
Sim GC; Radvanyi L
Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
[TBL] [Abstract][Full Text] [Related]
7. [Development of novel immunotherapy targeting cancer immune evasion].
Tamada K
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.
Romano G; Kwong LN
Cancer Metastasis Rev; 2018 Mar; 37(1):45-53. PubMed ID: 29270700
[TBL] [Abstract][Full Text] [Related]
9. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
Ramesh R; Ioannides CG; Roth JA; Chada S
Methods Mol Biol; 2010; 651():241-70. PubMed ID: 20686970
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in the Diagnosis and Treatment of Cancer.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
[TBL] [Abstract][Full Text] [Related]
12. The use of cytokines and chemokines in the cancer immunotherapy.
Amedei A; Prisco D; D' Elios MM
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):126-42. PubMed ID: 22894642
[TBL] [Abstract][Full Text] [Related]
13. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
Front Immunol; 2020; 11():1124. PubMed ID: 32655554
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
[TBL] [Abstract][Full Text] [Related]
15. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
16. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
17. Interleukins in cancer: from biology to therapy.
Briukhovetska D; Dörr J; Endres S; Libby P; Dinarello CA; Kobold S
Nat Rev Cancer; 2021 Aug; 21(8):481-499. PubMed ID: 34083781
[TBL] [Abstract][Full Text] [Related]
18. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
[TBL] [Abstract][Full Text] [Related]
19. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs Reprogram Tumor Immune Response.
Cao W; Cheng W; Wu W
Methods Mol Biol; 2018; 1699():67-74. PubMed ID: 29086368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
